• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchIN8bio
    Picture of IN8bio logo

    INAB — IN8bio News Story

    $1.050.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro CapNeutral
    • Market Cap
      $10.35m
    • Enterprise Value
      -$7.48m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • INAB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    INAB Dividends
    All News

    NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM

    Picture of IN8bio logoIN8bio
    12/11/2020 09:01
    NASDAQ TRADE HALT CONTINUES  INAB.O  REASON NOT AVAILABLE AT 03:58 AM
    

    Recent news on IN8bio

    See all news
    • IN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary

      06/08/2026 22:20
    • Biopharma firm IN8bio's Q2 net loss narrows as expenses decline

      06/08/2026 21:16
    • IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview

      03/08/2026 12:47
    • Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering

      01/06/2026 12:14
    • IN8bio Q1 net loss narrows as R&D expenses fall

      07/05/2026 21:43

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.